The Justice Department filed a complaint against Patrick Britton-Harr and several laboratory companies he owns for allegedly submitting claims to Medicare for tests that were not ordered by providers, not medically necessary and sometimes never performed. 

He Jiankui, PhD, a Chinese scientist who sparked controversy in 2018 after claiming to have genetically modified two human embryos, is on a new scientific endeavor: trying to develop a therapy for Duchenne muscular dystrophy, NPR reported June 8.

On Feb. 24, the FDA issued an emergency use authorization for the first over-the-counter rapid test that can detect both COVID-19 and flu. However, it's unclear when the test might be available to consumers as Lucira Health, the test's developer, faces financial challenges, according to Politico. 

Quest Diagnostics has agreed to acquire some laboratory services assets from New York City-based NewYork-Presbyterian.

A team of engineers and infectious disease researchers at Washington University in St. Louis developed a new rapid point-of-care diagnostic test that is 1,000 times more sensitive than conventional tests.

The FDA cleared for commercial distribution a diagnostic panel that tests for multiple respiratory viral and bacterial infections on Feb. 3.

Grand Junction, Colo.-based Saint Mary’s Hospital is opening a $52.8 million laboratory, ABC affiliate KJCT8 reported Feb. 1.

Kansas City-based University of Kansas Medical Center researchers created an artificial intelligence model that can predict urinary tract infection without a microscopy, WFMZ reported Jan. 23.

BD, a global medtech company, and CerTest Biotec have received emergency use authorization from FDA for their polymerase chain reaction mpox test. 

Labcorp has kicked off operations at an LA-based anatomic pathology and histology lab.

A Dec. 6 OIG report found that 378 labs billed Medicare Part B at questionably high levels for test add-ons.

Quest Diagnostics, a diagnostic information services provider, completed the acquisition of LabCare Plus, the laboratory services business unit of Akron, Ohio-based Summa Health.

Life Line Screening launched a new line of at-home lab test kits, including tests for women's health, men's health, sexual health and general wellness.

The American Society for Clinical Pathology updated its recommendations on ordering and administering certain lab tests.

Saint Louis (Mo.) University and Quest Diagnostics partnered to launch a new medical laboratory science program at the university. 

GC LabTech partnered with 1health.io to deliver new lab tests directly to consumers and grow into the at-home testing market. 

P4 Diagnostix has teamed up with Pierian, a genomics company that provides an analysis platform, to help physician-owned labs with next-generation sequencing.

Plexision created a new rapid blood test panel designed to provide results within six hours. 

Quest Diagnostics launched a new obstetrics test panel that is designed to allow physicians to easily test pregnant people for hepatitis C. 

Laboratory testing company Patients Choice Laboratories has acquired Infinity Laboratories for an undisclosed amount.